These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24713308)

  • 1. Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity.
    Mojzych M; Bielawska A; Bielawski K; Ceruso M; Supuran CT
    Bioorg Med Chem; 2014 May; 22(9):2643-7. PubMed ID: 24713308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors.
    Mojzych M; Ceruso M; Bielawska A; Bielawski K; Fornal E; Supuran CT
    Bioorg Med Chem; 2015 Jul; 23(13):3674-80. PubMed ID: 25921266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
    Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
    Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
    Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines.
    Abdel Gawad NM; Amin NH; Elsaadi MT; Mohamed FMM; Angeli A; De Luca V; Capasso C; Supuran CT
    Bioorg Med Chem; 2016 Jul; 24(13):3043-3051. PubMed ID: 27234893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR study of pyrazolo[4,3-e][1,2,4]triazine sulfonamides against tumor-associated human carbonic anhydrase isoforms IX and XII.
    Matysiak J; Skrzypek A; Tarasiuk P; Mojzych M
    Comput Biol Chem; 2017 Dec; 71():57-62. PubMed ID: 28964980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII.
    Alafeefy AM; Isik S; Abdel-Aziz HA; Ashour AE; Vullo D; Al-Jaber NA; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1396-403. PubMed ID: 23290254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents.
    Chegaev K; Lazzarato L; Tamboli Y; Boschi D; Blangetti M; Scozzafava A; Carta F; Masini E; Fruttero R; Supuran CT; Gasco A
    Bioorg Med Chem; 2014 Aug; 22(15):3913-21. PubMed ID: 25022971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
    Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
    Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
    Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5168-74. PubMed ID: 23867389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.
    Rogez-Florent T; Meignan S; Foulon C; Six P; Gros A; Bal-Mahieu C; Supuran CT; Scozzafava A; Frédérick R; Masereel B; Depreux P; Lansiaux A; Goossens JF; Gluszok S; Goossens L
    Bioorg Med Chem; 2013 Mar; 21(6):1451-64. PubMed ID: 23168081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
    J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
    Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Güzel-Akdemir Ö; Akdemir A; Karalı N; Supuran CT
    Org Biomol Chem; 2015 Jun; 13(23):6493-9. PubMed ID: 25967275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors.
    Lolak N; Akocak S; Bua S; Supuran CT
    Bioorg Chem; 2019 Feb; 82():117-122. PubMed ID: 30312866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling.
    Ghorab MM; Ceruso M; Alsaid MS; Nissan YM; Arafa RK; Supuran CT
    Eur J Med Chem; 2014 Nov; 87():186-96. PubMed ID: 25255434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.